Výsledky vyhledávání - "MESH: Urinary Bladder Neoplasms/urine"

Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine

Autor: Magali Court, Cédric Mesmin, François Radvanyi, Kevin Demeure, Mariette Matondo, Christophe Masselon, Núria Malats, Elodie Duriez, Jérôme Garin, Yves Allory, Bruno Domon

Publikováno v: Journal of Proteome Research
Journal of Proteome Research, 2017, 16 (4), pp.1617-1631. ⟨10.1021/acs.jproteome.6b00979⟩
Journal of Proteome Research, American Chemical Society, 2017, 16 (4), pp.1617-1631. ⟨10.1021/acs.jproteome.6b00979⟩

International audience; Urothelial bladder cancer is a condition associated with high recurrence and substantial morbidity and mortality. Noninvasive urinary tests that would detect bladder cancer and tumor recurrence are required to significantly im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e6fb36ddf7dc6f8093a4eaf5276568
https://hal.science/hal-02095567

Zobrazit plný text záznamu

Discrimination of agonist and antagonist forms of CXCL10 in biological samples

Autor: M. Schmolz, Stanislas Pol, L. Stephen, Matthew L. Albert, James Mapes, Armanda Casrouge, Vincent Mallet, C. Pfister, A. Bisiaux

Publikováno v: Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137-148. ⟨10.1111/j.1365-2249.2011.04488.x⟩
Clinical and Experimental Immunology, 2012, 167 (1), pp.137-148. ⟨10.1111/j.1365-2249.2011.04488.x⟩
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137-148. 〈10.1111/j.1365-2249.2011.04488.x〉

Summary The ready access to commercially available multiplex assays and the importance of inflammation in disease pathogenesis has resulted in an abundance of studies aimed at identifying surrogate biomarkers for different clinically important questi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebab0338538bea4fe091429d1a353338
https://hal-pasteur.archives-ouvertes.fr/pasteur-01402047

Zobrazit plný text záznamu

Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer

Autor: H. Barton Grossman, Juan Palou, Molly A. Ingersoll, Antonia Vlahou, Marta Sanchez-Carbayo, John A. Taylor, Bas W.G. van Rhijn, Wassim Kassouf, M´Liss A. Hudson, Peter J. Goebell, T. Todenhöfer, Bernd J. Schmitz-Dräger, Ashish Chandra, Thomas Behrens, Ashish M. Kamat, Beate Pesch

Publikováno v: Urologic Oncology: Seminars and Original Investigations
Urologic Oncology: Seminars and Original Investigations, Elsevier, 2014, 32 (7), pp.1069-1077. ⟨10.1016/j.urolonc.2014.06.017⟩
Urologic Oncology: Seminars and Original Investigations, 2014, 32 (7), pp.1069-1077. ⟨10.1016/j.urolonc.2014.06.017⟩

This article reflects and summarizes discussions held at the 10th Meeting of the International Bladder Cancer Network (IBCN e.V.), Nijmegen, The Netherlands, 20—22.9.2012.; International audience; OBJECTIVE: Diagnosis and surveillance of high risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c1042e493ab0c5b8b7647e24cf5534
https://hal-pasteur.archives-ouvertes.fr/pasteur-01384171

Zobrazit plný text záznamu

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer

Autor: Rossana Critelli, H. Barton Grossman, Tilman Todenhöfer, Wassim Kassouf, Bas W.G. van Rhijn, Molly A. Ingersoll, John A. Taylor, Antonia Vlahou, Marta Sanchez-Carbayo, Joan Palou, Mĺiss A. Hudson, Ashish Chandra, Thomas Behrens, Ashish M. Kamat, Bernd J. Schmitz-Dräger, Beate Pesch

Publikováno v: Urologic Oncology: Seminars and Original Investigations
Urologic Oncology: Seminars and Original Investigations, Elsevier, 2014, 32 (7), pp.1061-1068. ⟨10.1016/j.urolonc.2013.10.010⟩
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Urologic Oncology: Seminars and Original Investigations, 2014, 32 (7), pp.1061-1068. ⟨10.1016/j.urolonc.2013.10.010⟩

Objectives: Many molecular assays for bladder cancer diagnosis and surveillance have been developed over the past several decades. However, none of these markers have been routinely implemented into clinical decision making. Beyond their potential fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6a2bd9bacb4a7081dd282420b77be7
https://hal-pasteur.archives-ouvertes.fr/pasteur-01381004

Zobrazit plný text záznamu

Systematic quantification of peptides/proteins in urine using selected reaction monitoring

Autor: Mariette Matondo, Bruno Domon, Ruedi Aebersold, Nathalie Selevsek, Marta Sanchez Carbayo

Publikováno v: Proteomics
Proteomics, Wiley-VCH Verlag, 2011, 11 (6), pp.1135-1147. ⟨10.1002/pmic.201000599⟩
PROTEOMICS; Vol 11
PROTEOMICS

International audience; The evaluation of biomarkers in bodily fluids necessitates the development of robust methods to quantify proteins in a complex background, using large sets of samples. The ability to multiplex numerous analytes in a single ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0bacb0fbabcca6c1df526bd17108e0a
https://hal-pasteur.archives-ouvertes.fr/pasteur-02619035

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání